胆囊胆道外科著名教授（胆道外科的历史与发展）(3)
［14］KIM H, SONG KB, HWANG DW, et al. Laparoscopic versus open pancreaticoduodenectomy for pancreatic neuroendocrine tumors: A single-center experience［J］. Surg Endosc, 2019, 33(12): 4177-4185.
［15］TORPHY RJ, FRIEDMAN C, HALPERN A, et al. Comparing short-term and oncologic outcomes of minimally invasive versus open pancreaticoduodenectomy across low and high volume centers［J］. Ann Surg, 2019, 270(6): 1147-1155.
［16］MUNRO MG. The surgical “robot” in benign gynecology: Surgical advance or a set of costly training wheels［J］. J Minim Invasive Gynecol, 2016, 23(1): 1-4.
［17］ZHOU NX, CHEN JZ, LIU QD, et al. One hundred eighty cases of general surgeries under da vinci surgical system in single institute in China［J］. Chin J Bases Clin Gen Surg, 2011, 18(7): 698-704.（in Chinese）
周宁新, 陈军周, 刘全达, 等. “达芬奇”呆板人平凡外科手术180例：中国单中心报道［J］. 中国普外基本与临床杂志, 2011, 18(7): 698-704.
［18］DOU KF, ZHOU JS. Some problems in biliary surgery［J］. Chin J Exp Surg, 2007, 24(12): 1452-1453. （in Chinese）
窦科峰, 周景师. 胆道外科中应该重视的几个题目［J］. 中华尝试外科杂志, 2007, 24(12): 1452-1453.
［19］COPUR MS, MERANI S, VARGAS LM. Biliary cancer: Current multimodality treatment and future directions［J］. Oncology (Williston Park), 2019, 33(9): 685003.
［20］SIMILE MM, BAGELLA P, VIDILI G, et al. Targeted therapies in cholangiocarcinoma: Emerging evidence from clinical trials［J］. Medicina (Kaunas), 2019, 55(2): e42.
［21］SIMBOLO M, FASSAN M, RUZZENENTE A, et al. Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups ［J］. Oncotarget, 2014, 5(9): 2839-2852.
［22］BRIDGEWATER JA, GOODMAN KA, KALYAN A, et al. Biliary tract cancer: Epidemiology, radiotherapy, and molecular profiling［J］. Am Soc Clin Oncol Educ Book, 2016, 35: e194-e203.
［23］MERTENS JC, RIZVI S, GORES GJ. Targeting cholangiocarcinoma［J］. Biochim Biophys Acta Mol Basis Dis, 2018, 1864(4 Pt B): 1454-1460.
(责任编辑：admin)
国学经典故事（国学经典故
西施是哪里人，她的原名叫
李斯被腰斩死得冤
历史上的嘉庆杀和